A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer

Clinical trial NCT00375674 · COMPLETED

Trial details

NCT number: NCT00375674
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Kidney Neoplasms

Start date: 2007-08-01
Primary completion: 2016-04-07
Enrollment: 674

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.